NCT03714542
Prospective Evaluation of the Role of MRI in the Perioperative Management of Pancreas Adenocarcinomas No drug interventions diagnostic Not Available completed NCT02863471
Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma treatment 1 / 2 unknown_status NCT04034238
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors treatment 1 completed NCT06282809
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy No drug interventions treatment Not Available recruiting NCT03778879
Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B No drug interventions treatment 1 / 2 withdrawn NCT01401387
Pancreatic Enzyme Suppletion in Pancreatic Cancer No drug interventions treatment 4 withdrawn NCT00075647
CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT00063947
Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer treatment 1 completed NCT03717298
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma No drug interventions supportive_care 2 completed NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer treatment 1 completed NCT01145456
Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00096070
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer treatment 2 completed NCT06582342
Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients? No drug interventions Not Available Not Available recruiting NCT00735917
Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer treatment 2 completed NCT00028834
Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT04911816
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma treatment 1 / 2 recruiting NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT01192763
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer treatment 1 terminated NCT01064622
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT01357525
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma No drug interventions treatment Not Available completed NCT02037230
Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas treatment 1 / 2 completed NCT00366457
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer treatment 2 completed NCT00091026
Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT00095966
Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT01068327
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer treatment 1 completed NCT02030860
A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer treatment 1 completed NCT00383760
Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients treatment 2 completed NCT03490760
Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas treatment 2 terminated NCT01232829
Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer treatment 2 completed NCT04141995
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer treatment 2 active_not_recruiting NCT00039403
UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer treatment 1 completed NCT00114179
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT05419479
Switch Maintenance in Pancreatic treatment 1 / 2 recruiting NCT00462553
Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors treatment 1 completed NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT00585845
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment treatment 1 terminated NCT00020345
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas treatment 2 completed NCT02707328
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) treatment 1 terminated NCT04543071
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma treatment 2 recruiting NCT00948688
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas treatment 1 / 2 terminated NCT05821556
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients treatment 2 recruiting NCT02707315
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer treatment 0 unknown_status NCT01447732
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05043532
Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT00630552
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT03871959
Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma treatment 1 completed NCT01318642
Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas treatment 2 terminated NCT00609336
Perioperative Therapy for Resectable Pancreatic Cancer treatment 2 completed NCT01227018
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer treatment 2 terminated NCT00253526
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer treatment 2 withdrawn NCT00331682
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer treatment 2 completed NCT01484860
Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy treatment 2 terminated NCT00088894
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 3 completed NCT01222689
Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT00577889
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer treatment 2 completed NCT01497392
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers treatment 1 completed NCT00026104
Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer treatment 2 completed NCT05116072
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula No drug interventions treatment 1 / 2 recruiting NCT02564146
First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine treatment 2 completed NCT00474812
Dasatinib in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT00375310
Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer treatment 1 completed NCT03065985
EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma. No drug interventions device_feasibility 2 withdrawn NCT01359007
FOLFIRINOX in Patients With Inoperable Pancreatic Cancer treatment 2 terminated NCT05374876
Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy No drug interventions supportive_care Not Available completed NCT06592664
LSTA1 Phase 1b/2a Continuous Infusion Trial in mPDAC treatment 1 / 2 not_yet_recruiting NCT03492671
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer treatment 2 recruiting NCT04571294
Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy No drug interventions treatment Not Available recruiting NCT06208124
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04164602
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly No drug interventions Not Available Not Available recruiting NCT01413087
Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma treatment 2 terminated NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions other 1 recruiting NCT05351983
Patient-derived Organoids Drug Screen in Pancreatic Cancer No drug interventions other Not Available recruiting NCT04396093
Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24) No drug interventions Not Available Not Available unknown_status NCT05571956
Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy Samples No drug interventions basic_science Not Available recruiting NCT04998552
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma No drug interventions other Not Available recruiting NCT06277206
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT05161013
A Proof-of-Concept Study Evaluating LINFU™ No drug interventions device_feasibility Not Available completed NCT04821219
Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids No drug interventions treatment Not Available withdrawn NCT04099134
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma No drug interventions Not Available Not Available recruiting NCT06160596
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis No drug interventions Not Available Not Available recruiting NCT06315439
Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion No drug interventions Not Available Not Available completed NCT04045730
The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma. treatment 2 withdrawn NCT05825066
Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma treatment 2 recruiting NCT06464965
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer No drug interventions treatment 1 recruiting NCT06381882
The Role of the Human Microbiome in Patients After Pancreatic Resection. No drug interventions Not Available Not Available not_yet_recruiting NCT03616431
Pancreatic Cancer Dietary Assessment Study No drug interventions Not Available Not Available completed NCT06065891
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT03331562
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer treatment 2 completed NCT05376592
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT04241367
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy No drug interventions Not Available Not Available active_not_recruiting NCT04305067
PRECISE: Pancreatic Cancer and Exercise No drug interventions other Not Available completed NCT05340569
Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. No drug interventions diagnostic Not Available recruiting NCT06055010
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology No drug interventions Not Available Not Available recruiting NCT05325281
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma treatment 1 recruiting NCT03410914
Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy No drug interventions prevention 2 completed NCT04147403
A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma. No drug interventions Not Available Not Available unknown_status NCT03977233
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer treatment 2 recruiting NCT05915351
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) treatment 2 recruiting NCT06497777
The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT03532347
Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) No drug interventions diagnostic Not Available completed NCT06110598
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) supportive_care 2 withdrawn NCT05784597
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors No drug interventions diagnostic 1 recruiting NCT05518071
FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 No drug interventions treatment 2 completed NCT06349278
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX No drug interventions treatment Not Available recruiting NCT04636788
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer No drug interventions diagnostic Not Available unknown_status NCT06290856
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy No drug interventions Not Available Not Available recruiting NCT03822936
Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma treatment 2 unknown_status NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss treatment 1 / 2 withdrawn NCT04331041
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma treatment 2 recruiting NCT03472716
The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) No drug interventions Not Available Not Available active_not_recruiting NCT05884463
18F-FAPI PET Imaging in Pancreatic Adenocarcinoma diagnostic Not Available completed NCT05356039
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT05470920
Genetic Testing Decision Aid No drug interventions health_services_research Not Available recruiting NCT03377491
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) treatment 3 active_not_recruiting NCT01774162
EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration No drug interventions diagnostic Not Available completed NCT04435067
Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial) No drug interventions Not Available Not Available unknown_status NCT05984810
NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 No drug interventions treatment 2 recruiting NCT03544255
Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues No drug interventions Not Available Not Available unknown_status NCT01783054
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas treatment 0 terminated NCT01456585
Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma treatment 1 completed NCT01315548
Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses No drug interventions Not Available Not Available completed NCT02404363
Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy treatment 3 terminated NCT02028377
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma No drug interventions diagnostic Not Available completed NCT02812992
Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients treatment 4 completed NCT01703650
Role of Perfusion CT in Pancreatic Cancer Not Available Not Available unknown_status NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 active_not_recruiting NCT03245541
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT04452461
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery treatment 2 recruiting NCT04548752
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations treatment 2 recruiting NCT05365581
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer treatment 1 recruiting NCT05673811
Study of Nab-Paclitaxel and Gemcitabine and Plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer treatment 2 active_not_recruiting NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02070705
DCE MRI in Patients With Pancreatic Cancer diagnostic Not Available active_not_recruiting NCT04157127
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma No drug interventions treatment 1 active_not_recruiting NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 treatment 2 recruiting NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types treatment 1 / 2 recruiting NCT05877599
A Study of NT-175 in Adult Subjects with Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation No drug interventions treatment 1 recruiting NCT06026943
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available not_yet_recruiting NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI treatment 2 recruiting NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06483555
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel treatment 1 / 2 not_yet_recruiting NCT06596915
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT01825603
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer treatment 1 completed NCT00909103
Endoscopic Ultrasound Elastography in Pancreatic Masses No drug interventions Not Available Not Available completed NCT02680990
Resilience and Exercise in Advanced Cancer Treatment No drug interventions treatment Not Available completed NCT03592264
A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors treatment 1 / 2 terminated NCT03307564
Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer No drug interventions treatment Not Available completed NCT00637364
High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain No drug interventions treatment 1 / 2 suspended NCT01474564
Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT03105921
Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma No drug interventions treatment Not Available completed NCT02514421
Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma treatment 1 completed NCT03570502
Incidence of POPF in the Resection of the Left Pancreas With RFAT No drug interventions Not Available Not Available unknown_status NCT02045602
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors treatment 1 completed NCT04236102
KEBI-Cyto Study - Use of the Biocartis Idylla No drug interventions diagnostic Not Available completed NCT01753479
Spectroscopy From Duodenum No drug interventions diagnostic Not Available completed NCT04002479
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT06466187
A Study of SGN-MesoC2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03152487
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis No drug interventions treatment Not Available completed NCT01897454
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer treatment 2 terminated NCT04814251
Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study No drug interventions Not Available Not Available not_yet_recruiting NCT01921751
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery treatment 2 terminated NCT00854477
Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma basic_science 4 completed NCT05287347
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort No drug interventions Not Available Not Available not_yet_recruiting NCT03578445
Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions No drug interventions diagnostic Not Available completed NCT03507998
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors treatment 1 unknown_status NCT01699698
Pancreatic Juice Diagnosis From Duodenum No drug interventions diagnostic Not Available completed NCT05056805
An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study No drug interventions supportive_care Not Available withdrawn NCT03318497
Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma No drug interventions diagnostic 2 completed NCT01016483
Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer treatment 1 / 2 completed NCT05546411
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer treatment 2 terminated NCT04406571
Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer No drug interventions Not Available Not Available completed NCT06157671
The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available enrolling_by_invitation NCT01783171
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT02736578
Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery diagnostic 2 terminated NCT04167007
FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX treatment 3 recruiting NCT02896907
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery treatment 0 completed NCT02638909
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies treatment 2 terminated NCT01674556
Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer treatment 1 completed NCT02202785
A Study of MLN0264 in Patients With Pancreatic Cancer treatment 2 terminated NCT04098237
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency supportive_care 2 recruiting NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT05077800
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer treatment 2 recruiting NCT00728000
Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma treatment 2 withdrawn NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors treatment 1 terminated NCT02757859
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery No drug interventions treatment Not Available recruiting NCT02743975
Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma diagnostic 1 / 2 terminated NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT04298242
Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment No drug interventions device_feasibility Not Available completed NCT04130399
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer No drug interventions treatment 2 withdrawn NCT06115499
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer treatment 2 / 3 recruiting NCT03202199
Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma. No drug interventions diagnostic Not Available unknown_status NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT01839799
A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma treatment 2 completed NCT01765036
Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma diagnostic Not Available completed NCT04137536
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer No drug interventions treatment 1 active_not_recruiting NCT05624918
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma treatment 2 recruiting NCT06095141
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency treatment 2 / 3 recruiting NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT01989624
PAncreatic Adenocarcinoma in Hospital No drug interventions Not Available Not Available completed NCT06024824
Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) No drug interventions treatment 1 / 2 recruiting NCT02495896
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors treatment 1 terminated NCT03816358
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer treatment 1 active_not_recruiting NCT02775786
Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma No drug interventions diagnostic Not Available active_not_recruiting NCT06341725
EUS Role in Non-metastatic Pancreatic Adenocarcinoma Lymph Nodes Staging No drug interventions Not Available Not Available terminated NCT03307148
Stromal TARgeting for PAncreatic Cancer (STAR_PAC) treatment 1 completed NCT03559348
Locally Advanced or Metastatic Pancreatic Adenocarcinoma treatment 2 completed NCT03266757
Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT04400357
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors No drug interventions treatment Not Available unknown_status NCT05494866
A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 terminated NCT02838966
Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation) No drug interventions other Not Available terminated NCT03080974
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma treatment 2 recruiting NCT01369420
NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer No drug interventions treatment 2 completed NCT03138720
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer treatment 2 active_not_recruiting NCT01726582
Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") treatment 2 completed NCT05973331
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model No drug interventions Not Available Not Available active_not_recruiting NCT00327327
Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma treatment 1 completed NCT03401827
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer treatment 4 unknown_status NCT03840460
A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers No drug interventions Not Available Not Available unknown_status NCT03404960
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy treatment 1 / 2 active_not_recruiting NCT02206360
Pancreatic Cancer Early Detection Program No drug interventions Not Available Not Available active_not_recruiting NCT00598091
A Phase I/Expansion Study of Dasatinib treatment 1 terminated NCT04119362
PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer No drug interventions Not Available Not Available completed NCT03703089
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology treatment 1 unknown_status NCT06149689
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer No drug interventions treatment 2 recruiting NCT03225989
Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer treatment 1 / 2 active_not_recruiting NCT05268692
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP No drug interventions treatment 2 / 3 recruiting NCT03468244
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms No drug interventions treatment Not Available unknown_status NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT01389440
Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer treatment 2 completed NCT06388967
Pancreatic Cancer Detection Consortium No drug interventions Not Available Not Available recruiting NCT03147768
Laser Tissue Welding - Distal Pancreatectomy Sealing Study No drug interventions device_feasibility 1 completed NCT01558869
Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma treatment 2 completed NCT02124369
Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) treatment 2 terminated NCT04627246
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer treatment 1 recruiting NCT02896946
Diffusion MRI for Pancreatic Adenocarcinoma No drug interventions diagnostic Not Available completed NCT05752812
The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT03673423
Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT02575508
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT00593008
Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer treatment 1 terminated NCT04539808
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer treatment 2 recruiting NCT02839343
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT04303403
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma treatment 1 recruiting NCT06405490
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC treatment 2 recruiting NCT03193190
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) treatment 1 / 2 active_not_recruiting NCT03871790
Peptide-based Immunization for Colon- and and Pancreas-carcinoma No drug interventions Not Available Not Available completed NCT04835064
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. treatment 3 not_yet_recruiting NCT05247164
EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients No drug interventions diagnostic Not Available recruiting NCT01419002
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer No drug interventions treatment 3 terminated NCT04436679
INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors No drug interventions Not Available Not Available recruiting NCT02133079
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 No drug interventions treatment 1 / 2 unknown_status NCT02174887
Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer treatment 1 completed NCT02586987
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours treatment 1 completed NCT02806687
Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer treatment 2 completed NCT02336087
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery treatment 1 active_not_recruiting NCT03054987
Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction No drug interventions treatment Not Available completed NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas treatment 1 recruiting NCT00644254
The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT03063554
EUS BD vs ERCP TP for Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT03415854
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) treatment 2 completed NCT01919151
Micrometastasis in Gastrointestinal Cancer No drug interventions Not Available Not Available unknown_status NCT00574977
Safety Study of Modified Vaccinia Virus to Cancer treatment 1 completed NCT01764477
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma treatment 1 completed NCT05083247
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma treatment 2 recruiting NCT06055647
HER-2 Expression in Pancreatic Duct Adenocarcinoma No drug interventions Not Available Not Available completed NCT05181605
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors No drug interventions treatment 2 / 3 recruiting NCT03678883
9-ING-41 in Patients With Advanced Cancers treatment 2 active_not_recruiting NCT04400383
Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors No drug interventions treatment 1 completed NCT00769483
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer treatment 1 / 2 completed NCT04289961
PDAC Peripheral and Portal Vein Sampling No drug interventions diagnostic Not Available completed NCT01660711
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma treatment 2 completed NCT00288093
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery treatment 1 completed NCT06552078
Activation of Biobank Registry for Bilio-pancreatic Diseases No drug interventions Not Available Not Available recruiting NCT02333188
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT03373188
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer treatment 1 completed NCT04983407
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma treatment 1 / 2 terminated NCT04992507
Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study No drug interventions treatment 2 completed NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors No drug interventions treatment 1 recruiting NCT03073785
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer treatment 2 recruiting NCT03528785
A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer treatment 2 unknown_status NCT02207985
Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma No drug interventions treatment 1 / 2 terminated NCT03723915
Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer treatment 2 terminated NCT02496832
A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo diagnostic Not Available withdrawn NCT04143152
Pancreatic Cancer Biomarker Study No drug interventions Not Available Not Available active_not_recruiting NCT04902352
The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT03376659
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma treatment 1 / 2 terminated NCT01764659
4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation No drug interventions Not Available Not Available completed NCT03435770
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms No drug interventions treatment Not Available unknown_status NCT01834170
EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer treatment 1 completed NCT05776342
Prognostic and Predictive Markers of Treatment Response in Patients With PAC. No drug interventions Not Available Not Available recruiting NCT06387342
Namodenoson Treatment of Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT05737706
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation No drug interventions treatment 1 / 2 recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT01013649
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery treatment 3 active_not_recruiting NCT04483349
Assessment of What Patients and Healthcare Providers Value No drug interventions Not Available Not Available completed NCT06135649
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy No drug interventions Not Available Not Available recruiting NCT02749136
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer treatment 2 completed NCT04605913
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC No drug interventions treatment 1 / 2 recruiting NCT05988918
Multicenter Trial of ESK981 in Patients With Select Solid Tumors treatment 2 recruiting NCT04837118
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study No drug interventions supportive_care Not Available active_not_recruiting NCT02879318
Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma treatment 2 active_not_recruiting NCT03159819
Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma No drug interventions treatment Not Available unknown_status NCT02427841
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery treatment 2 completed NCT03665441
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC treatment 3 completed NCT03784417
EUS-guided Laser Ablation in Pancreatic Adenocarcinoma No drug interventions treatment Not Available terminated NCT02562716
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery treatment 2 completed NCT05482516
Evaluating Novel Therapies in ctDNA Positive GI Cancers treatment 3 recruiting NCT02072616
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. No drug interventions diagnostic 3 unknown_status NCT01206296
Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma treatment 2 terminated NCT03856658
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases treatment 2 recruiting NCT03126435
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX treatment 3 completed NCT03649035
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma No drug interventions treatment 3 withdrawn NCT02394535
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer treatment 1 completed NCT03703063
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer treatment 1 unknown_status NCT03865563
Selective Transvenous Chemoembolization of Primary Pancreatic Tumors treatment 1 withdrawn NCT03567863
Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles No drug interventions diagnostic Not Available completed NCT04986930
mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma No drug interventions treatment 2 recruiting NCT03745430
RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma treatment 1 / 2 completed NCT04257448
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT05380557
ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing No drug interventions Not Available Not Available terminated NCT06217666
Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) No drug interventions treatment 1 not_yet_recruiting NCT02850874
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma treatment 2 withdrawn NCT05585320
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05239182
9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma treatment 2 active_not_recruiting NCT02723331
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates treatment 2 active_not_recruiting NCT03451773
M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas treatment 1 / 2 terminated NCT03033927
Predicting Effective Therapy in Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02550327
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer treatment 0 completed NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT02345460
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study treatment 2 terminated NCT00154791
Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma treatment 1 / 2 completed NCT02818829
Biological and Clinical Database for Pancreatic Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT04270929
Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma treatment 1 withdrawn NCT02045589
A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer treatment 1 completed NCT06102889
GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES No drug interventions Not Available Not Available enrolling_by_invitation NCT00203892
Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma treatment 1 / 2 completed NCT03140592
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue No drug interventions Not Available Not Available unknown_status NCT02349867
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer treatment 1 completed NCT04926467
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) treatment 2 not_yet_recruiting NCT05305001
Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico No drug interventions Not Available Not Available completed NCT01959672
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer treatment 2 completed NCT05226572
Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results No drug interventions Not Available Not Available completed NCT04077372
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers No drug interventions supportive_care Not Available terminated NCT06250972
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer treatment 3 recruiting NCT01365169
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" No drug interventions health_services_research Not Available recruiting NCT04773769
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas No drug interventions treatment Not Available unknown_status NCT02781012
Project Survival-Prospective Biomarker Discovery No drug interventions Not Available Not Available unknown_status NCT01543412
Second Line Chemotherapy for Advanced Pancreatic Cancer treatment 2 completed NCT00638612
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01) treatment 1 completed NCT06412510
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT No drug interventions supportive_care 1 / 2 recruiting NCT04765410
The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT01971281
Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) treatment 1 / 2 unknown_status NCT05400681
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT02592395
Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma No drug interventions treatment 1 withdrawn NCT06199895
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer treatment 2 recruiting NCT05795595
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03851614
Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors treatment 2 active_not_recruiting NCT01144455
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma treatment 2 completed NCT01274455
Gene Therapy of Pancreatic Ductal Adenocarcinoma No drug interventions treatment 1 completed NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT02620423
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma treatment 1 completed NCT04361708
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies treatment 1 recruiting NCT05228808
Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT03384238
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery diagnostic 1 / 2 recruiting NCT03483038
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma treatment 2 active_not_recruiting NCT05657743
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting